ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,039 filers reported holding ASTRAZENECA PLC in Q4 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $274 | 0.0% | 3,831 | -3.1% | 0.02% | -5.6% |
| Q1 2023 | $274 | +2.2% | 3,952 | 0.0% | 0.02% | +5.9% |
| Q4 2022 | $268 | -100.0% | 3,952 | -99.2% | 0.02% | -99.1% |
| Q3 2022 | $28,051,000 | -16.8% | 511,511 | +0.2% | 1.98% | -14.8% |
| Q2 2022 | $33,717,000 | +15437.8% | 510,328 | +14036.5% | 2.32% | +17753.8% |
| Q3 2021 | $217,000 | -97.8% | 3,610 | -98.0% | 0.01% | -98.2% |
| Q3 2020 | $9,779,000 | +50.0% | 178,440 | +44.7% | 0.74% | +19.9% |
| Q2 2020 | $6,521,000 | +15.4% | 123,296 | -2.5% | 0.61% | -5.5% |
| Q1 2020 | $5,649,000 | -67.1% | 126,488 | -63.2% | 0.65% | -57.1% |
| Q4 2019 | $17,157,000 | +8.7% | 344,108 | -2.8% | 1.51% | +9.7% |
| Q3 2019 | $15,786,000 | +5.0% | 354,179 | -2.7% | 1.38% | +9.0% |
| Q2 2019 | $15,031,000 | +2.1% | 364,129 | +0.0% | 1.26% | +1.9% |
| Q1 2019 | $14,719,000 | +6.0% | 364,070 | -0.5% | 1.24% | -7.5% |
| Q4 2018 | $13,891,000 | – | 365,750 | – | 1.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |